BACKGROUND: Tuberculosis (TB) is a major global cause of mortality and morbidity, and host genetic factors influence disease susceptibility. Interferon-gamma mediates immunity to mycobacteria and rare mutations in the interferon-gamma receptor-1 gene (IFNGR1) result in increased susceptibility to mycobacterial infection, including TB, in affected families. The role of genetic variation in IFNGR1 in susceptibility to common mycobacterial diseases such as pulmonary TB in outbred populations has not previously been investigated. METHODS: The association between IFNGR1 and susceptibility to pulmonary TB was investigated in a Gambian adult population sample using a case-control study design. The coding and promoter regions of IFNGR1 were sequenced in 32 patients with pulmonary TB, and the frequencies of six common IFNGR1 polymorphisms were determined using PCR based methods in 320 smear positive TB cases and 320 matched controls. Haplotypes were estimated from the genotype data using the expectation-maximisation algorithm. RESULTS: There was no association between the IFNGR1 variants studied and TB in this Gambian population sample. Three common haplotypes were identified within the study population, none of which was associated with TB. CONCLUSIONS: These data represent an important negative finding and suggest that, while IFNGR1 is implicated in rare Mendelian susceptibility to mycobacterial disease, the common variants studied here do not have a major influence on susceptibility to pulmonary TB in The Gambian population.
BACKGROUND:Tuberculosis (TB) is a major global cause of mortality and morbidity, and host genetic factors influence disease susceptibility. Interferon-gamma mediates immunity to mycobacteria and rare mutations in the interferon-gamma receptor-1 gene (IFNGR1) result in increased susceptibility to mycobacterial infection, including TB, in affected families. The role of genetic variation in IFNGR1 in susceptibility to common mycobacterial diseases such as pulmonary TB in outbred populations has not previously been investigated. METHODS: The association between IFNGR1 and susceptibility to pulmonary TB was investigated in a Gambian adult population sample using a case-control study design. The coding and promoter regions of IFNGR1 were sequenced in 32 patients with pulmonary TB, and the frequencies of six common IFNGR1 polymorphisms were determined using PCR based methods in 320 smear positive TB cases and 320 matched controls. Haplotypes were estimated from the genotype data using the expectation-maximisation algorithm. RESULTS: There was no association between the IFNGR1 variants studied and TB in this Gambian population sample. Three common haplotypes were identified within the study population, none of which was associated with TB. CONCLUSIONS: These data represent an important negative finding and suggest that, while IFNGR1 is implicated in rare Mendelian susceptibility to mycobacterial disease, the common variants studied here do not have a major influence on susceptibility to pulmonary TB in The Gambian population.
Authors: C A Mein; B J Barratt; M G Dunn; T Siegmund; A N Smith; L Esposito; S Nutland; H E Stevens; A J Wilson; M S Phillips; N Jarvis; S Law; M de Arruda; J A Todd Journal: Genome Res Date: 2000-03 Impact factor: 9.043
Authors: E Jouanguy; F Altare; S Lamhamedi; P Revy; J F Emile; M Newport; M Levin; S Blanche; E Seboun; A Fischer; J L Casanova Journal: N Engl J Med Date: 1996-12-26 Impact factor: 91.245
Authors: R de Jong; F Altare; I A Haagen; D G Elferink; T Boer; P J van Breda Vriesman; P J Kabel; J M Draaisma; J T van Dissel; F P Kroon; J L Casanova; T H Ottenhoff Journal: Science Date: 1998-05-29 Impact factor: 47.728
Authors: M J Newport; C M Huxley; S Huston; C M Hawrylowicz; B A Oostra; R Williamson; M Levin Journal: N Engl J Med Date: 1996-12-26 Impact factor: 91.245
Authors: Y Tanaka; H Nakashima; C Hisano; T Kohsaka; Y Nemoto; H Niiro; T Otsuka; T Otsuka; T Imamura; Y Niho Journal: Immunogenetics Date: 1999-04 Impact factor: 2.846
Authors: F Altare; D Lammas; P Revy; E Jouanguy; R Döffinger; S Lamhamedi; P Drysdale; D Scheel-Toellner; J Girdlestone; P Darbyshire; M Wadhwa; H Dockrell; M Salmon; A Fischer; A Durandy; J L Casanova; D S Kumararatne Journal: J Clin Invest Date: 1998-12-15 Impact factor: 14.808
Authors: M A Salih; M E Ibrahim; J M Blackwell; E N Miller; E A G Khalil; A M ElHassan; A M Musa; H S Mohamed Journal: Genes Immun Date: 2006-11-30 Impact factor: 2.676
Authors: Giorgio Sirugo; Branwen J Hennig; Adebowale A Adeyemo; Alice Matimba; Melanie J Newport; Muntaser E Ibrahim; Kelli K Ryckman; Alessandra Tacconelli; Renato Mariani-Costantini; Giuseppe Novelli; Himla Soodyall; Charles N Rotimi; Raj S Ramesar; Sarah A Tishkoff; Scott M Williams Journal: Hum Genet Date: 2008-05-30 Impact factor: 4.132
Authors: Catherine M Stein; Sarah Zalwango; Allan B Chiunda; Christopher Millard; Dmitry V Leontiev; Amanda L Horvath; Kevin C Cartier; Keith Chervenak; W Henry Boom; Robert C Elston; Roy D Mugerwa; Christopher C Whalen; Sudha K Iyengar Journal: Hum Genet Date: 2007-04-13 Impact factor: 5.881
Authors: Mohammad Varahram; Parissa Farnia; Mohammad Javad Nasiri; Mona Afraei Karahrudi; Mehdi Kazempour Dizagie; Ali Akbar Velayati Journal: Mediterr J Hematol Infect Dis Date: 2014-02-16 Impact factor: 2.576
Authors: Mohamed A M Salih; Michaela Fakiola; Mohamed H Abdelraheem; Brima M Younis; Ahmed M Musa; Ahmed M ElHassan; Jenefer M Blackwell; Muntaser E Ibrahim; Hiba S Mohamed Journal: BMC Infect Dis Date: 2014-12-03 Impact factor: 3.090
Authors: Paula Keiko Sato; Felipe Delatorre Busser; Flávia Mendes da Cunha Carvalho; Alexandra Gomes Dos Santos; Aya Sadahiro; Constancia Lima Diogo; Adriana Satie Gonçalves Kono; Maria Luiza Moretti; Olinda do Carmo Luiz; Maria Aparecida Shikanai-Yasuda Journal: Front Immunol Date: 2020-10-01 Impact factor: 7.561